 "PlasmaGen BioSciences raises $25 mn from Eight Roads Ventures, F-Prime")
Biopharmaceutical company PlasmaGen BioSciences announced an investment of $25 million (Rs 160 crore) led by Eight Roads Ventures and US-based F-Prime Capital Partners.
PlasmaGeb BioSciences, which specialises in blood plasma derived products, is founded by serial entrepreneur Vinod Nahar, who also founded RSM Pharma and Trigenesis Lifesciences.
The company's chief executive officer Ranjeet S Ajmani said: “There is a large gap between demand and supply of plasma products, not only in India but across Asia. India is strategically placed as an emerging economy with a huge demand potential.”
Eight Roads Venture is the investment arm of Fidelity International that
